Interferon and amantadine in combination as initial treatment for chronic hepatitis C patients
- 1 October 2001
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 35 (4) , 517-521
- https://doi.org/10.1016/s0168-8278(01)00166-0
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- In vitro effect of amantadine and interferon α-2a on hepatitis C virus markers in cultured peripheral blood mononuclear cells from hepatitis C virus-infected patientsAntiviral Research, 1999
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virusPublished by Elsevier ,1998
- Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C: Meta-analysis of individual patient data from European centersJournal of Hepatology, 1997
- The Treatment of Chronic Viral HepatitisNew England Journal of Medicine, 1997
- Treatment of Chronic Hepatitis C with AmantadineDigestive Diseases and Sciences, 1997
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assayJournal of General Virology, 1993
- Interferon for non-A, non-B chronic hepatitis: A meta-analysis of randomised clinical trialsJournal of Hepatology, 1991
- Clinical Pharmacokinetics of Amantadine HydrochlorideClinical Pharmacokinetics, 1988